INNOVATIVE FEDERAL STRATEGIES, LLC for IMMUNE DESIGN
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
HR 5136 / S 3454, National Defense Authorization Act, 2011, Title II, all provisions relating to development of vaccines for biodefense and infectious diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA EGGIMANN | — |
| DAVID FREDERICK KILIAN | — |
| AMANDA KING | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Budget/Appropriations BUD
HR ____, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to development of vaccines for biodefense and infectious diseases. HR ____, Department of Labor, Health and Human Services Appropriations Act, 2011, Title II, all provisions relating to development of vaccines for infectious diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA EGGIMANN | — |
| DAVID FREDERICK KILIAN | — |
| AMANDA KING | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.